Investing in companies that are in the midst of transformational changes implies high risks, but there's sometimes the promise of rich rewards too. On that note, Aurora Cannabis (NASDAQ: ACB) is a business amid a major transition, with its fortunes (and the fortunes of its investors) in flux in the short term.

With its shares free-falling by more than 97% over the last three years, it's possible that shareholders will soon get a reprieve, but it isn't guaranteed. Let's map out the cultivator's next 12 months to see what it's trying to do and whether it has a chance of getting there so that it's easier to make a judgment about whether to invest.

Right now, Aurora's situation is tenuous. 

Continue reading

Source Fool.com